With the analysis among 710,062 patents, we discovered top 462 key players by total patent application. F. Hoffmann-La Roche Ltd., Novartis AG, AstraZeneca Pharmaceutical Co., Ltd. are dominant in this area. They take 5.42% of the total patent filing.
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 15,099
Basel-Stadt, Switzerland
Patent: 14,901
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 8,519
New York, United States
Patent: 7,573
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 6,940
New York, United States
Patent: 6,514
Antwerpen, Belgium
Patent: 6,274
California, United States
Patent: 5,963
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 5,722
California, United States
Patent: 5,426
With the analysis among 15,872 patents, we discovered top 382 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Biosplice Therapeutics, Inc., Cellix Bio Pvt Ltd. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Biosplice Therapeutics, Inc.
California, United States
Patent: 261
Telangana, India
Patent: 229
California, United States
Patent: 202
DUBLIN, Ireland
Patent: 164
California, United States
Patent: 149
Phanes Therapeutics, Inc.
California, United States
Patent: 126
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 121
Intarcia Therapeutics, Inc.
California, United States
Patent: 110
Prevail Therapeutics, Inc.
New York, United States
Patent: 109
With the analysis among related 183,433 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Novartis AG, F. Hoffmann-La Roche Ltd., Regents of the University of California take 2.22% of patent filing during this period.
Basel-Stadt, Switzerland
Patent: 1,691
F. Hoffmann-La Roche Ltd.
Regents of the University of California
California, United States
Patent: 1,172
Delaware, United States
Patent: 1,100
Institut National de la Santé et de la Recherche Médicale
New York, United States
Patent: 1,013
Antwerpen, Belgium
Patent: 995
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 973
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 939
Nordrhein-Westfalen, Germany
Patent: 847
With the analysis among related 183,433 patents in last 5 years, we discover 29 new entrants. Aligos Therapeutics, Inc., Inflazome Ltd., BicycleTx Ltd. are the most active new entrants in this area.
Aligos Therapeutics, Inc.
California, United States
Patent: 166
DUBLIN, Ireland
Patent: 164
Cambridgeshire, United Kingdom
Patent: 143
Texas, United States
Patent: 136
Phanes Therapeutics, Inc.
California, United States
Patent: 126
Abbisko Therapeutics Co., Ltd.
Shanghai Shi, China
Patent: 123
New York, United States
Patent: 113
Prevail Therapeutics, Inc.
New York, United States
Patent: 109
California, United States
Patent: 106
Suzhou Yasheng Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 98
With the analysis among 163,709 patents, we discovered top 290 universities and scientific research institutions by total patent application. The Johns Hopkins University, President & Fellows of Harvard College, Yale University are dominant in this area. They take 7.32% of the total patent filing.
The Johns Hopkins University
United States
Patent: 2,032
President & Fellows of Harvard College
Massachusetts, United States
Patent: 1,815
Connecticut, United States
Patent: 1,364
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 1,304
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 1,280
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 1,161
The Scripps Research Institute
California, United States
Patent: 1,145
Shanghai Shi, China
Patent: 1,037
North Carolina, United States
Patent: 1,019
Consejo Superior de Investigaciones Científicas